Basic info
Industry
biotechnology research
Sectors
immune-evasive
Biotechnology
AXL
Pharmaceutical
Biopharma
oncology
Date founded
2000
Funding rounds raised
Total raised
$131M
from 17 investors over 17 rounds
S
Symphogen raised $76M on October 22, 2015
Investors: PKA and Novo Holdings
S
Symphogen raised $54M on May 3, 2013
Investors: Danica Pension, PKA and Novo Holdings
S
Symphogen raised $131M on January 6, 2011
Investors: PKA and Novo Holdings
S
Symphogen raised $6.5M on February 1, 2007
Investors: Gilde Healthcare
S
Symphogen raised $25M on January 10, 2006
Investors: LD Fonde, Takeda UK Limited, Vækstfonden and Novo Holdings
S
Symphogen raised $25M on November 5, 2004
Investors: LD Fonde and Novo Holdings
S
Symphogen raised $15M on January 22, 2002
Investors: Madison Alley Global Ventures, Danske Bank and Novo Holdings